Bayer AG annual shareholders’ equity
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Shareholders’ Equity Growth & History (BAYN)
Bayer AG's shareholders’ equity was €25.95B for fiscal 2025.
View full Bayer AG company overviewBayer AG annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €25.95B | −€5.96B | −18.68% |
| 2024 | 2024-12-31 | €31.91B | −€1.02B | −3.09% |
| 2023 | 2023-12-31 | €32.93B | −€5.85B | −15.08% |
| 2022 | 2022-12-31 | €38.77B | €5.75B | +17.42% |
| 2021 | 2021-12-31 | €33.02B | €2.50B | +8.18% |
| 2020 | 2020-12-31 | €30.52B | −€16.81B | −35.52% |
| 2019 | 2019-12-31 | €47.34B | €1.36B | +2.96% |
| 2018 | 2018-12-31 | €45.98B | €9.18B | +24.93% |
| 2017 | 2017-12-31 | €36.80B | €6.47B | +21.32% |
| 2016 | 2016-12-31 | €30.33B | €6.07B | +25.01% |
| 2015 | 2015-12-31 | €24.27B | €4.16B | +20.69% |
| 2014 | 2014-12-31 | €20.11B | −€612.0M | −2.95% |
| 2013 | 2013-12-31 | €20.72B | €2.25B | +12.18% |
| 2012 | 2012-12-31 | €18.47B | −€743.0M | −3.87% |
| 2011 | 2011-12-31 | €19.21B | €379.0M | +2.01% |
| 2010 | 2010-12-31 | €18.83B | — | — |
Bayer AG quarterly shareholders’ equity
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €29.58B | −€786.0M | −2.59% |
| Q1 2026 | 2026-03-31 | €28.84B | — | — |
| Q4 2025 | 2025-12-31 | €25.95B | — | — |
| Q3 2025 | 2025-09-30 | €29.58B | — | — |
| Q2 2025 | 2025-06-30 | €30.37B | — | — |
Bayer AG shareholders’ equity trends
Over the last five fiscal years, Bayer AG's shareholders’ equity decreased from €30.52B to €25.95B, a change of −€4.58B. The latest reported quarter, Q2 2026, shows €29.58B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
